Company Filing History:
1 out of 15,528 
1 out of 20 
1 out of 7 Years Active: 2015
Title: The Innovations of Jason R. Clapper in Pain Management
Introduction
Jason R. Clapper, an inventive researcher based in Irvine, California, has made significant strides in the field of pharmacology focusing on pain management. He holds a patent dedicated to the development of peripherally restricted inhibitors of fatty acid amide hydrolase (FAAH), showcasing his dedication to advancing medical therapies.
Latest Patents
Jason R. Clapper is recognized for his patent titled "Peripherally Restricted FAAH Inhibitors." This invention addresses the challenge of persistent pain by providing compounds that can effectively suppress FAAH activity and increase anandamide levels outside the central nervous system (CNS). The compounds demonstrate a unique ability to reduce behavioral responses in rodent models exhibiting inflammation or peripheral nerve injury, while also inhibiting noxious stimulus-evoked neuronal activation in spinal cord areas associated with pain processing. The patent outlines various pharmaceutical compositions and methods aimed at treating conditions where peripheral FAAH inhibition is beneficial.
Career Highlights
Throughout his career, Clapper has worked with esteemed institutions such as the University of California and Università degli Studi di Parma. His role in these institutions has enabled him to contribute to important research that impacts pain management therapies.
Collaborations
Jason has collaborated with prominent figures in the field, including Daniele Piomelli and Guillermo Moreno-Sanz. These collaborations have fostered a rich environment for innovation, leading to advancements in pharmacological research and applications.
Conclusion
In summary, Jason R. Clapper is a notable inventor whose work in the development of FAAH inhibitors represents a significant advancement in the treatment of pain. His contributions reflect a blend of academic excellence and innovative thinking, positioning him as a valuable asset to the scientific community focused on pain management.